Dermatology Doctors in Wailuku, HI Accepting Medicare

4 Dermatology doctors found. Showing 1 - 4

May M. Zhang, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 80 Mahalani St, Wailuku, HI 96793 Phone: 808-243-6000

Dr. Jac Daniel Marden, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 99 S Market St Ste 206, Wailuku, HI 96793 Phone: 808-249-8600

Patti K.m. Endo, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1830 Wells St 102, Wailuku, HI 96793 Phone: 808-877-3635    Fax: 808-877-4363

Gary Salenger, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2180 Main St, Wailuku, HI 96793 Phone: 808-242-6464    Fax: 808-243-2321

News Archive

Study focuses on precipitating circumstances of suicide in children and early adolescents

According to the Centers for Disease Control and Prevention, suicide was the 10th leading cause of death for children ages 5 to 11 in 2014. This was the first time suicide had shown up in the CDC's top ten leading causes of death for children in this age group.

Doctors still waiting to be paid after Katrina

Almost 400 doctors at a New Orleans hospital are suing the state for $100 million for treatment and care they provided to uninsured patients following Hurricane Katrina.

Male therapists are just as likely as female therapists to encourage patients to admit infidelities

"Contrary to the perception that male counselors are less likely to reveal infidelity, because men in our society have more liberal attitudes about affairs and are more likely to have had them, that did not turn out to be the case in our study," said Rosaria Carlone Upchurch, who did the research for her doctoral dissertation in counselor education.

Naïve B cells can neutralize SARS-CoV-2 via RBD recognition

A new preprint research paper posted to the bioRxiv server demonstrates the potential of using the pre-existing protective responses to produce a broad-spectrum neutralizing response against not just SARS-CoV-2 but other future pathogens.

FDA clears Lorus' LOR-253 IND application for treatment of hematologic malignancies

Lorus Therapeutics Inc. today announced that the Food and Drug Administration completed its review and cleared the company's Investigational New Drug (IND) application of LOR-253 for the treatment of hematologic malignancies including acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS), lymphomas and multiple myeloma.

Read more Medical News

› Verified 8 days ago